Securities Code: 002044
Securities Abbreviation: Meinian Healthcare
Announcement Number: 2026-057
Meinian Healthcare Holdings Co., Ltd.
Announcement on Termination of Share Issuance for Asset Purchase and Withdrawal of Application Documents
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Meinian Healthcare Holdings Co., Ltd. (hereinafter referred to as "Meinian Healthcare" or "the Company") held the twenty-fifth (extraordinary) meeting of the Ninth Board of Directors on July 17, 2026, and reviewed and approved the "Proposal on Terminating the Share Issuance for Asset Purchase and Withdrawal of Application Documents." The Company agreed to terminate the share issuance for asset purchase and withdraw the application documents. The relevant situation is hereby announced as follows:
I. Basic Situation of the Transaction
Meinian Healthcare planned to acquire 84.00% equity of Hengyang Meinian Healthcare Examination Center Co., Ltd., 81.00% equity of Ningde Meinian Healthcare Management Co., Ltd., 75.00% equity of Yantai Meinian Healthcare Examination Management Co., Ltd., 49.00% equity of Yantai Meinian Futian Health Examination Management Co., Ltd., 52.81% equity of Wuhan Meici Aoya Technology Management Co., Ltd., 85.00% equity of Sanming Meinian Healthcare Management Co., Ltd., 90.00% equity of Feicheng Meinian Healthcare Management Co., Ltd., 84.00% equity of Dezhou Meinian Healthcare Examination Management Co., Ltd., 82.00% equity of Lianjiang Meinian Healthcare Management Co., Ltd., 80.50% equity of Yishui Meinian Healthcare Examination Management Co., Ltd., 92.35% equity of Shandong Meiming Aoya Health Consulting Co., Ltd., and 47.37% minority equity of its holding subsidiary Zhengzhou Meijian Health Management Co., Ltd., 49.00% minority equity of Guangzhou Huadu Meinian Healthcare Management Co., Ltd., 42.46% minority equity of Anhui Meixin Health Management Consulting Co., Ltd., 49.00% minority equity of Zibo Meinian Healthcare Management Co., Ltd., and 48.05% minority equity of Jilin Changyi Meinian Healthcare Technology Management Co., Ltd. (hereinafter referred to as "this Transaction").
According to the "Administrative Measures for Major Asset Restructuring of Listed Companies" and other relevant laws and regulations, this transaction constitutes a related-party transaction, does not constitute a major asset restructuring, does not constitute a restructuring for backdoor listing, and will not lead to a change in the actual controller of the company.
II. Work Done by the Company During the Process of This Transaction
During the planning and promotion of this transaction, the Company strictly followed the relevant regulations of the China Securities Regulatory Commission (hereinafter referred to as "CSRC") and the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") and organized relevant parties to actively carry out various tasks related to this transaction. The Company held board meetings and shareholder meetings to review and approve the proposals related to this transaction; hired independent financial advisors, auditing firms, appraisal firms, legal advisors, and other intermediary agencies to conduct due diligence, audits, and appraisals of the target companies; and conducted multiple communications, negotiations, and discussions with the parties to the transaction regarding the transaction plan. During the planning and promotion of this transaction, the Company fulfilled its information disclosure obligations in a timely manner and warned investors of the uncertainty risks of this restructuring. The main process of this transaction is as follows:
- On April 14, 2025, the Company held the seventh (extraordinary) meeting of the Ninth Board of Directors and the twenty-eighth (extraordinary) meeting of the Eighth Supervisory Board, and reviewed and approved the "Proposal on the Draft Report and Summary of the Proposal for Meinian Healthcare Holdings Co., Ltd. Issuing Shares to Purchase Assets and Related Party Transactions," and other proposals related to this transaction. For details, please refer to the relevant documents disclosed by the Company on the Juchao Information Network (www.cninfo.com.cn) on April 15, 2025.